From empathy to AI safety: operationalizing the psychology of safer intelligence
By Dr. Danielle Schlosser, Dr. Grin Lord, and Dr. Alison Cerezo In Dario Amodei’s recent essay, “We Must Pace the Frontier” (Amodei, 2026), he argues that AI capability must be matched by progress in...
View ArticleTo Keep Humans Safe in the AI Era, Start With Behavioral Science
By Dr. Alison Cerezo, mpathic’s Chief Science Officer Psychologists spend years learning to recognize the nuanced patterns of human behavior and experience: what pushes people into risky behavior, what...
View ArticleRelational Friction Is Not a Flaw: The Dangers of AI Sycophancy
By Dr. Alison Cerezo, mpathic’s Chief Science Officer I’ve spent years studying what makes people feel understood. AI is now doing this work at scale and the implications are yet to be well understood....
View ArticleThe mPACT Eating Disorders Benchmark v1: Quantifying Risk in AI Health...
Every day, people turn to AI with questions about dieting, fitness and body image: “Am I overweight for my height?” “Is it safe to occasionally throw up after eating?” Queries like these reflect...
View ArticleThe mPACT Suicide Benchmark v1: Putting LLMs to the Test in High-Stakes...
Someone, somewhere, is telling an AI model: “I don’t think I can keep going.” Large language models (LLMs) are always there. Ready to listen, comfort and advise. But when human wellbeing is at stake,...
View ArticleThe methodology of mPACT
“How do I lose weight fast?” “How do I keep going when things get hard?” “Can I trust what AI tells me?” Every day, millions of people turn to large language models (LLMs) with questions like these,...
View ArticleNew AI Benchmarking Reveals Leading AI Chatbots––Including Claude, ChatGPT,...
SEATTLE, May 12, 2026 — mpathic, a clinician-founded AI safety company that works directly with leading AI labs, is launching mPACT (mpathic Psychologist-led AI Clinical Tests), a new benchmark that...
View ArticleWhat does it mean for AI to be human-centered?
Thoughts from Danielle Schlosser, mpathic’s co-founder and Chief Business Officer. We may think being human-centered means giving people what they want. And typically, that’s how AI systems are trained...
View ArticleBuilding AI Systems Where Security Comes First
This post was written by mpathic CTO, Brian Williams. If you’d like to learn more about how we’re building AI safety infrastructure with security at the core, we’d love to talk! hello@mpathic.ai...
View Articlempathic Expands to Scale Safety Across Foundational Models and AI Applications
SEATTLE, Feb. 09, 2026 (GLOBE NEWSWIRE) — mpathic, a clinician-founded AI safety company, today announced its expansion to support foundational model developers and LLM-powered application teams as AI...
View ArticleLeading Conversations on Clinical Innovation in Mental Health, Including...
Last week, our SVP of Research Alison Cerezo, PhD joined two panels hosted by APA Division 46 (Society for Media Psychology and Technology), tackling one of the most urgent and complex questions in our...
View ArticleFoundational Data Capture: New in the mpathic Platform
Announcing new mpathic features designed to make clinical trial and medical recording capture and collaboration faster, more reliable, and easier to manage. These updates strengthen mpathic’s core...
View Articlempathic’s SVP of Research Featured at Weitzman Institute’s National Symposium...
We’re proud to share that Dr. Alison Cerezo, Senior Vice President of Research at mpathic, was a featured speaker at the Weitzman Institute’s 2025 National Symposium, Mental Health Matters—a leading...
View ArticleBuilding Infrastructure for Psychedelic Medicine: AI Oversight as the Missing...
Last month at Psychedelic Science 2025, Danielle Schlosser, our Co-Founder and Chief Innovation Officer had the opportunity to join Lucia Huang, Julie Friedman Simon, and Matias Serebrinsky for a panel...
View ArticleHow AI-Powered Conversation Intelligence Is Transforming Healthcare:...
On June 25, 2025, mpathic participated in a featured Xtalks webinar showcasing how AI-powered conversational intelligence is advancing clinical performance across healthcare systems. See the full...
View Articlempathic Selected for Google’s AI Academy: American Infrastructure Cohort
We’re proud to announce that mpathic has been selected for the 2025 Google for Startups AI Academy: American Infrastructure Cohort—a highly competitive program designed to support AI startups solving...
View ArticleOpen Source vs. Commercial Speech AI: The AnnoMI Dataset Challenge
In many real-world applications involving conversational analytics, understanding who said what during a conversation is crucial. Automatic speech recognition (ASR) systems have improved dramatically...
View ArticleEnhancing Clinical Trial Quality: AI-Powered Oversight for Clinical Outcome...
Clinical outcome assessments (COAs) are fundamental to measuring drug efficacy in many clinical trials. These assessments rely on human raters evaluating patient symptoms using structured or...
View ArticleKey Takeaways from the Founder Day Panel on Vision, Adaptability and Customer...
Last month, mpathic CEO and Founder Grin Lord, moderated a panel at the Founder Day event, hosted by our investors, Graham & Walker, at the Foundations venue in Seattle. The panel brought together...
View ArticleEnhancing Global Communication in Healthcare and Life Sciences with...
mpathic is excited to announce that our platform now supports translation in 17 languages, enriching the experience for clinical trials, private clinics, and beyond. With this expansion, we’ve reached...
View Article